LIP

Clinical trials for LIP explained in plain language.

Never miss a new study

Get alerted when new LIP trials appear

Sign up with your email to follow new studies for LIP, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Terminated 1

Could an immunotherapy combo replace harsh chemo for head and neck cancer?

Disease control Ongoing

This phase II trial tests whether combining the immunotherapy drug durvalumab (Imfinzi) with radiation therapy can effectively treat intermediate-risk head and neck cancer after surgery, while causing fewer serious side effects than the standard cisplatin-based chemo-radiation. T…

Matched conditions: LIP

Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control

Last updated Jun 27, 2026 14:03 UTC

LIP

Get alerted when new LIP trials appear

Could an immunotherapy combo replace harsh chemo for head and neck cancer?